Author

Linyan Tian

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Clinicopathological Profiles and Prognosis of Postoperative HER2-Mutant Non-Small Cell Lung Cancer: A Real-World Analysis.

Her2-mutant NSCLC constitutes a distinct subtype characterized by unique clinicopathological and molecular features and for postoperative patients presenting with advanced disease or an increased burden of high-risk recurrence factors, more aggressive therapeutic strategies should be considered.

Guang-Jian Yang, Linyan Tian, Xiao-Yong Tang et al. · Current Cancer Drug Targets · 0 citations

Review Open access Aug 2026

Circulating tumor DNA dynamics and mutational profiles as indicators in neoadjuvant chemoimmunotherapy for resectable or borderline resectable non-small cell lung cancer

Longitudinal ctDNA assessment identified high-risk subgroups in neoadjuvant NSCLC, particularly by refining prognosis in heterogeneous SD populations, and an exploratory gene-based mutational signature provided potential molecular risk stratification.

Wenxin Jiang, Si-Yu Lei, Sijie Liu et al. · Respiratory Research · 0 citations